Apellis stock jumps nearly 8% as investors look to JPM healthcare update
New York, Jan 7, 2026, 12:14 PM EST — Regular session Apellis Pharmaceuticals shares rose nearly 8% on Wednesday, outperforming the broader market as traders positioned ahead of the company’s scheduled appearance at next week’s J.P. Morgan Healthcare Conference. investors.apellis.com The Waltham, Massachusetts-based drugmaker said on Monday it will present on Jan. 12 at 11:15 a.m. PT, with a live webcast posted to its investor site and a replay available afterward. Big healthcare conferences often bring fresh guidance, new trial details or partnering chatter — and the tape tends to price that in early. investors.apellis.com Apellis was last up $1.91